研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2019 年的期刊文章 · 第 24 页
共 1232 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2019-02-01 到 2019-01-15。
按期刊、按主题看 →
AoS Networks & Graphs · 发表于 2019-02-01
Karl Rohe
摘要
Web crawling, snowball sampling, and respondent-driven sampling (RDS) are three types of network sampling techniques used to contact individuals in hard-to-reach populations. This paper studies these procedures as a Markov process on the social network that is indexed by a tree. Each node in this tree corresponds to an observation and each edge in the tree corresponds to a referral. Indexing with a tree (instead of a chain) allows for the sampled units to refer multiple future units into the sample. In survey sampling, the design effect characterizes the additional variance induced by a novel sampling strategy. If the design effect is some value $\operatorname{DE}$, then constructing an estimator from the novel design makes the variance of the estimator $\operatorname{DE}$ times greater than it would be under a simple random sample with the same sample size $n$. Under certain assumptions on the referral tree, the design effect of network sampling has a critical threshold that is a function of the referral rate $m$ and the clustering structure in the social network, represented by the second eigenvalue of the Markov transition matrix, $\lambda_{2}$. If $m1/\lambda_{2}^{2}$, then the design effect grows with $n$ (i.e., the standard estimator is no longer $\sqrt{n}$-consistent). Past this critical threshold, the standard error of the estimator converges at the slower rate of $n^{\log_{m}\lambda_{2}}$. The Markov model allows for nodes to be resampled; computational results show that the findings hold in without-replacement sampling. To estimate confidence intervals that adapt to the correct level of uncertainty, a novel resampling procedure is proposed. Computational experiments compare this procedure to previous techniques.
SiM Longitudinal Data · 发表于 2019-01-31
Sara J. Baart, Eric Boersma, Dimitris Rizopoulos
摘要
Studies with longitudinal measurements are common in clinical research. Particular interest lies in studies where the repeated measurements are used to predict a time‐to‐event outcome, such as mortality, in a dynamic manner. If event rates in a study are low, however, and most information is to be expected from the patients experiencing the study endpoint, it may be more cost efficient to only use a subset of the data. One way of achieving this is by applying a case‐cohort design, which selects all cases and only a random samples of the noncases. In the standard way of analyzing data in a case‐cohort design, the noncases who were not selected are completely excluded from analysis; however, the overrepresentation of the cases will lead to bias. We propose to include survival information of all patients from the cohort in the analysis. We approach the fact that we do not have longitudinal information for a subset of the patients as a missing data problem and argue that the missingness mechanism is missing at random. Hence, results obtained from an appropriate model, such as a joint model, should remain valid. Simulations indicate that our method performs similar to fitting the model on a full cohort, both in terms of parameters estimates and predictions of survival probabilities. Estimating the model on the classical version of the case‐cohort design shows clear bias and worse performance of the predictions. The procedure is further illustrated in data from a biomarker study on acute coronary syndrome patients, BIOMArCS.
SiM Genetics & Omics · 发表于 2019-01-31
Zhongxue Chen, Kai Wang
摘要
Detecting the association between a set of variants and a phenotype of interest is the first and important step in genetic and genomic studies. Although it attracted a large amount of attention in the scientific community and several related statistical approaches have been proposed in the literature, powerful and robust statistical tests are still highly desired and yet to be developed in this area. In this paper, we propose a powerful and robust association test, which combines information from each individual single‐nucleotide polymorphisms based on sequential independent burden tests. We compare the proposed approach with some popular tests through a comprehensive simulation study and real data application. Our results show that, in general, the new test is more powerful; the gain in detecting power can be substantial in many situations, compared to other methods.
SiM Nonparametric & Semiparametric Survival Analysis · 发表于 2019-01-30
Mingyue Du, Tao Hu, Jianguo Sun
摘要
Semiparametric probit models have recently attracted some attention for regression analysis of failure time data partly due to the popularity of the normal distribution and its special features. In this paper, we discuss the fitting of such models to informative current status data, which often occur in many areas such as medical studies and whose analysis has also recently attracted a lot of attention. For inference, a sieve maximum likelihood approach is developed and the methodology is further generalized to a class of generalized semiparametric probit models. A simulation study is conducted to assess the finite sample properties of the presented approach and indicates that it works well in practical situations. An application that motivated this study is provided.
SMMR Clinical Trials Longitudinal Data Machine Learning · 发表于 2019-01-30
Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, Bruno Dubois, Harald Hampel, Stanley Durrleman, for the Alzheimer’s Disease Neuroimaging Initiative* and the INSIGHT-preAD study
摘要
We propose a method for recruiting asymptomatic Amyloid positive individuals in clinical trials, using a two-step process. We first select during a pre-screening phase a subset of individuals which are more likely to be amyloid positive based on the automatic analysis of data acquired during routine clinical practice, before doing a confirmatory PET-scan to these selected individuals only. This method leads to an increased number of recruitments and to a reduced number of PET-scans, resulting in a decrease in overall recruitment costs. We validate our method on three different cohorts, and consider five different classification algorithms for the pre-screening phase. We show that the best results are obtained using solely cognitive, genetic and socio-demographic features, as the slight increased performance when using MRI or longitudinal data is balanced by the cost increase they induce. We show that the proposed method generalizes well when tested on an independent cohort, and that the characteristics of the selected set of individuals are identical to the characteristics of a population selected in a standard way. The proposed approach shows how Machine Learning can be used effectively in practice to optimize recruitment costs in clinical trials.
SiM Longitudinal Data · 发表于 2019-01-30
Kyle M. Irimata, Jennifer Broatch, Jeffrey R. Wilson
摘要
Correlation is inherent in longitudinal studies due to the repeated measurements on subjects, as well as due to time‐dependent covariates in the study. In the National Longitudinal Study of Adolescent to Adult Health (Add Health), data were repeatedly collected on children in grades 7‐12 across four waves. Thus, observations obtained on the same adolescent were correlated, while predictors were correlated with current and future outcomes such as obesity status, among other health issues. Previous methods, such as the generalized method of moments (GMM) approach have been proposed to estimate regression coefficients for time‐dependent covariates. However, these approaches combined all valid moment conditions to produce an averaged parameter estimate for each covariate and thus assumed that the effect of each covariate on the response was constant across time. This assumption is not necessarily optimal in applications such as Add Health or health‐related data. Thus, we depart from this assumption and instead use the Partitioned GMM approach to estimate multiple coefficients for the data based on different time periods. These extra regression coefficients are obtained using a partitioning of the moment conditions pertaining to each respective relationship. This approach offers a deeper understanding and appreciation into the effect of each covariate on the response. We conduct simulation studies, as well as analyses of obesity in Add Health, rehospitalization in Medicare data, and depression scores in a clinical study. The Partitioned GMM methods exhibit benefits over previously proposed models with improved insight into the nonconstant relationships realized when analyzing longitudinal data.
SiM Causal Inference · 发表于 2019-01-30
Fei Wan
摘要
Propensity‐score matching has been used widely in observational studies to balance confounders across treatment groups. However, whether matched‐pairs analyses should be used as a primary approach is still in debate. We compared the statistical power and type 1 error rate for four commonly used methods of analyzing propensity‐score–matched samples with continuous outcomes: (1) an unadjusted mixed‐effects model, (2) an unadjusted generalized estimating method, (3) simple linear regression, and (4) multiple linear regression. Multiple linear regression had the highest statistical power among the four competing methods. We also found that the degree of intraclass correlation within matched pairs depends on the dissimilarity between the coefficient vectors of confounders in the outcome and treatment models. Multiple linear regression is superior to the unadjusted matched‐pairs analyses for propensity‐score–matched data.
SiM Longitudinal Data High-Dimensional · 发表于 2019-01-30
Samrachana Adhikari, Fabrizio Lecci, James T. Becker, Brian W. Junker, Lewis H. Kuller, Oscar L. Lopez, Ryan J. Tibshirani
摘要
We study regularized estimation in high‐dimensional longitudinal classification problems, using the lasso and fused lasso regularizers. The constructed coefficient estimates are piecewise constant across the time dimension in the longitudinal problem, with adaptively selected change points (break points). We present an efficient algorithm for computing such estimates, based on proximal gradient descent. We apply our proposed technique to a longitudinal data set on Alzheimer's disease from the Cardiovascular Health Study Cognition Study. Using data analysis and a simulation study, we motivate and demonstrate several practical considerations such as the selection of tuning parameters and the assessment of model stability. While race, gender, vascular and heart disease, lack of caregivers, and deterioration of learning and memory are all important predictors of dementia, we also find that these risk factors become more relevant in the later stages of life.
SiM Machine Learning Networks & Graphs · 发表于 2019-01-30
Jialiang Li, Ming Gao, Ralph D'Agostino
摘要
Deep learning neural network models such as multilayer perceptron (MLP) and convolutional neural network (CNN) are novel and attractive artificial intelligence computing tools. However, evaluation of the performance of these methods is not readily available for practitioners yet. We provide a tutorial for evaluating classification accuracy for various state‐of‐the‐art learning approaches, including familiar shallow and deep learning methods. For qualitative response variables with more than two categories, many traditional accuracy measures such as sensitivity, specificity, and area under the receiver operating characteristic curve are not applicable and we have to consider their extensions properly. In this paper, a few important statistical concepts for multicategory classification accuracy are reviewed and their utilities for various learning algorithms are demonstrated with real medical examples. We offer problem‐basedRcode to illustrate how to perform these statistical computations step by step. We expect that such analysis tools will become more familiar to practitioners and receive broader applications in biostatistics.
SMMR Other · 发表于 2019-01-30
Anthony J Hatswell, William G Sullivan
摘要
Where medical interventions are licensed based on only uncontrolled study data (for example a single-arm trial), a common approach for estimating the incremental benefit is to compare the treatment to a ‘historical control’; data collected from patients who did not receive the intervention. We illustrate with motivating examples two methods for the creation of historical controls where disease progression and overall survival are typically the key clinically meaningful endpoints. The first method utilises information routinely collected in a clinical trial programme: patients’ time to disease progression on their previous line of treatment against which outcomes can be compared. The second uses published clinical outcomes for the prior line of treatment which can be extrapolated to estimate outcomes at the next line. As examples we use two pharmaceuticals licensed on the basis of uncontrolled clinical studies – idelalisib for double-refractory follicular lymphoma and ofatumumab for double-refractory chronic lymphocytic leukemia. Although subject to limitations that should be considered on a case-by-case basis, the methods may be appropriate when trying to quantify the clinical benefit of treatment based on limited and uncontrolled trial data. As a result, the methods can be used to inform health technology adoption decisions.
Biometrika Testing & Uncertainty Networks & Graphs · 发表于 2019-01-29
Aaditya Ramdas, Jianbo Chen, Martin J Wainwright, Michael I Jordan
摘要
We propose a linear-time, single-pass, top-down algorithm for multiple testing on directed acyclic graphs, where nodes represent hypotheses and edges specify a partial ordering in which the hypotheses must be tested. The procedure is guaranteed to reject a sub-directed acyclic graph with bounded false discovery rate while satisfying the logical constraint that a rejected node’s parents must also be rejected. It is designed for sequential testing settings where the directed acyclic graph structure is known a priori but the |$p$|-values are obtained selectively, such as in a sequence of experiments; however, the algorithm is also applicable in nonsequential settings where all |$p$|-values can be calculated in advance, such as in model selection. Our algorithm provably controls the false discovery rate under independence, positive dependence or arbitrary dependence of the |$p$|-values and specializes to known algorithms in the special cases of trees and line graphs; it simplifies to the classical Benjamini–Hochberg procedure when the directed acyclic graph has no edges. We explore the empirical performance of our algorithm through simulations and analysis of a real dataset corresponding to a gene ontology, and we demonstrate its favourable performance in terms of computational time and power. *(abstract via OpenAlex)*
Biometrics Latent Variables & Mixtures · 发表于 2019-01-28
W. Zhang, M. V. Bravington, R. M. Fewster
摘要
Latent count models constitute an important modeling class in which a latent vector of counts, , is summarized or corrupted for reporting, yielding observed data where is a known but non-invertible matrix. The observed vector generally follows an unknown multivariate distribution with a complicated dependence structure. Latent count models arise in diverse fields, such as estimation of population size from capture-recapture studies; inference on multi-way contingency tables summarized by marginal totals; or analysis of route flows in networks based on traffic counts at a subset of nodes. Currently, inference under these models relies primarily on stochastic algorithms for sampling the latent vector , typically in a Bayesian data-augmentation framework. These schemes involve long computation times and can be difficult to implement. Here, we present a novel maximum-likelihood approach using likelihoods constructed by the saddlepoint approximation. We show how the saddlepoint likelihood may be maximized efficiently, yielding fast inference even for large problems. For the case where has a multinomial distribution, we validate the approximation by applying it to a specific model for which an exact likelihood is available. We implement the method for several models of interest, and evaluate its performance empirically and by comparison with other estimation approaches. The saddlepoint method consistently gives fast and accurate inference, even when is dominated by small counts.
Biometrics Clinical Trials Testing & Uncertainty · 发表于 2019-01-28
Guoqing Diao, Guanghan F. Liu, Donglin Zeng, William Wang, Xianming Tan, Joseph F. Heyse, Joseph G. Ibrahim
摘要
It is an important and yet challenging task to identify true signals from many adverse events that may be reported during the course of a clinical trial. One unique feature of drug safety data from clinical trials, unlike data from post-marketing spontaneous reporting, is that many types of adverse events are reported by only very few patients leading to rare events. Due to the limited study size, the p-values of testing whether the rate is higher in the treatment group across all types of adverse events are in general not uniformly distributed under the null hypothesis that there is no difference between the treatment group and the placebo group. A consequence is that typically fewer than percent of the hypotheses are rejected under the null at the nominal significance level of . The other challenge is multiplicity control. Adverse events from the same body system may be correlated. There may also be correlations between adverse events from different body systems. To tackle these challenging issues, we develop Monte-Carlo-based methods for the signal identification from patient-reported adverse events in clinical trials. The proposed methodologies account for the rare events and arbitrary correlation structures among adverse events within and/or between body systems. Extensive simulation studies demonstrate that the proposed method can accurately control the family-wise error rate and is more powerful than existing methods under many practical situations. Application to two real examples is provided.
SiM Clinical Trials Econometrics & Economics · 发表于 2019-01-28
Ivair R. Silva, Wilson M. Lopes, Philipe Dias, W. Katherine Yih
摘要
Sequential analysis hypothesis testing is now an important tool for postmarket drug and vaccine safety surveillance. When the number of adverse events accruing in time is assumed to follow a Poisson distribution, and if the baseline Poisson rate is assessed only with uncertainty, the conditional maximized sequential probability ratio test, CMaxSPRT, is a formal solution. CMaxSPRT is based on comparing monitored data with historical matched data, and it was primarily developed under a flat signaling threshold. This paper demonstrates that CMaxSPRT can be performed under nonflat thresholds too. We pose the discussion in the light of the alpha spending approach. In addition, we offer a rule of thumb for establishing the best shape of the signaling threshold in the sense of minimizing expected time to signal and expected sample size. An example involving surveillance for adverse events after influenza vaccination is used to illustrate the method.
Biometrics Other · 发表于 2019-01-28
Jake M. Ferguson, Tanya A. Miura, Craig R. Miller
摘要
Dilution assays to determine solute concentration have found wide use in biomedical research. Many dilution assays return imprecise concentration estimates because they are only done to orders of magnitude. Previous statistical work has focused on how to design efficient experiments that can return more precise estimates, however this work has not considered the practical difficulties of implementing these designs in the laboratory. We developed a two-stage experiment with a first stage that obtains an order of magnitude estimate and a second stage that concentrates effort on the most informative dilution to increase estimator precision. We show using simulations and an empirical example that the best two-stage experimental designs yield estimates that are remarkably more accurate than standard methods with equivalent effort. This work demonstrates how to utilize previous advances in experimental design in a manner consistent with current laboratory practice. We expect that multi-stage designs will prove to be useful for obtaining precise estimates with minimal experimental effort.
Biometrics Nonparametric & Semiparametric Clinical Trials · 发表于 2019-01-28
Wei Zhang, Aiyi Liu, Larry L. Tang, Qizhai Li
摘要
Multiple endpoints are often naturally clustered based on their scientific interpretations. Tests that compare these clustered outcomes between independent groups may lose efficiency if the cluster structures are not properly accounted for. For the two-sample generalized Behrens-Fisher hypothesis concerning multiple endpoints we propose a cluster-adjusted multivariate test procedure for the comparison and demonstrate its gain in efficiency over test procedures that ignore the clusters. Data from a dietary intervention trial are used to illustrate the methods.
Biometrics Meta-Analysis & Data Integration Bayesian Methods Clinical Trials · 发表于 2019-01-28
Jincheng Zhou, James S. Hodges, M. Fareed K. Suri, Haitao Chu
摘要
Noncompliance to assigned treatment is a common challenge in analysis and interpretation of randomized clinical trials. The complier average causal effect (CACE) approach provides a useful tool for addressing noncompliance, where CACE is defined as the average difference in potential outcomes for the response in the subpopulation of subjects who comply with their assigned treatments. In this article, we present a Bayesian hierarchical model to estimate the CACE in a meta-analysis of randomized clinical trials where compliance may be heterogeneous between studies. Between-study heterogeneity is taken into account with study-specific random effects. The results are illustrated by a re-analysis of a meta-analysis comparing the effect of epidural analgesia in labor versus no or other analgesia in labor on the outcome cesarean section, where noncompliance varied between studies. Finally, we present simulations evaluating the performance of the proposed approach and illustrate the importance of including appropriate random effects and the impact of over- and under-fitting.
SiM Survival Analysis · 发表于 2019-01-24
Chi Hyun Lee, Jing Ning, Richard J. Kryscio, Yu Shen
摘要
The Nun Study, a longitudinal study to examine risk factors for the progression of dementia, consists of subjects who were already diagnosed with dementia (ie, prevalent cohort) and those who do not have dementia (ie, incident cohort) at study enrollment. When assessing the risk factors' effects on the survival time from dementia diagnosis until death, utilizing data from both cohorts supports more efficient statistical inference because the two cohorts provide valuable complementary information. A major challenge in analyzing the combined cohort data is that the prevalent cases are not representative of the target population. Moreover, the dates of dementia diagnosis are not ascertained for the prevalent cohort in the Nun Study. Hence, the survival time for the prevalent cohort is only partially observed from study enrollment until death or censoring, with the time from dementia diagnosis to study enrollment missing. In this paper, we propose an efficient estimation method that uses both incident and prevalent cohorts under the proportional mean residual life model. By assuming proportionality of the mean residual life time with covariates in the incident cohort, we can utilize the natural relationship between the mean residual life function and the hazard function of the survival time measured from enrollment until death for the prevalent cohort. We evaluate the efficiency gain from using the combined cohort data through simulations and demonstrate that the proposed method is valid and efficient.
SMMR Survival Analysis · 发表于 2019-01-23
C Touraine, N Grafféo, R Giorgi, and the CENSUR working survival group
摘要
Relative survival methods used to estimate the excess mortality of cancer patients rely on the background (or expected) mortality derived from general population life tables. These methods are based on splitting the observed mortality into the excess mortality and the background mortality. By assuming a regression model for the excess mortality, usually a Cox-type model, one may investigate the effects of certain covariates on the excess mortality. Some covariates are cancer-specific whereas others are variables that may influence the background mortality as well. The latter should be taken into account in the background mortality to avoid biases in estimating their effects on the excess mortality. Unfortunately, the available life table might not include such variables and, consequently, might provide inaccurate values of the background mortality. We propose a model that uses multiplicative parameters to correct potentially inaccurate background mortality. The model can be seen as an extension of the frequently used Estève model because we assume a Cox-type model for the excess mortality with a piecewise constant baseline function and introduce additional parameters that multiply the background mortality. The original and the extended model are compared, first in a simulation study, then in an application to colon cancer registry data.
SMMR Testing & Uncertainty Clinical Trials · 发表于 2019-01-23
Meghan I Short, Howard J Cabral, Janice M Weinberg, Michael P LaValley, Joseph M Massaro
摘要
Estimating the precision of a single proportion via a 100(1−α)% confidence interval in the presence of clustered data is an important statistical problem. It is necessary to account for possible over-dispersion, for instance, in animal-based teratology studies with within-litter correlation, epidemiological studies that involve clustered sampling, and clinical trial designs with multiple measurements per subject. Several asymptotic confidence interval methods have been developed, which have been found to have inadequate coverage of the true proportion for small-to-moderate sample sizes. In addition, many of the best-performing of these intervals have not been directly compared with regard to the operational characteristics of coverage probability and empirical length. This study uses Monte Carlo simulations to calculate coverage probabilities and empirical lengths of five existing confidence intervals for clustered data across various true correlations, true probabilities of interest, and sample sizes. In addition, we introduce a new score-based confidence interval method, which we find to have better coverage than existing intervals for small sample sizes under a wide range of scenarios.
SMMR Spatial & Time Series Diagnostics & Prediction · 发表于 2019-01-23
Yuan Wang, Jianhua Hu, Chaan S Ng, Brian P Hobbs
摘要
Perfusion computed tomography is an emerging functional imaging modality that uses physiological models to quantify characteristics pertaining to the passage of fluid through blood vessels. Perfusion characteristics provide physiological correlates for neovascularization induced by tumor angiogenesis and thus a quantitative basis for cancer detection, prognostication, and treatment monitoring. We consider a liver cancer study where patients underwent a dynamic computed tomography protocol to enable evaluation of multiple perfusion characteristics derived from interrogating the time-attenuation of the concentration of the intravenously administered contrast medium. The objective is to determine the effectiveness of using perfusion characteristics to identify and discriminate between regions of liver that contain malignant tissues from normal tissue. Each patient contributes multiple regions of interest which are spatially correlated due to the shared vasculature. We propose a multivariate functional data model to disclose the correlation over time and space as well as the correlation among multiple perfusion characteristics. We further propose a simultaneous classification approach that utilizes all the correlation information to predict class assignments for collections of regions. The proposed method outperforms conventional classification approaches in the presence of strong spatial correlation. The method offers maximal relative improvement in the presence of temporal sparsity wherein measurements are obtainable at only a few time points.
Biometrika Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2019-01-22
W W Zhuang, B Y Hu, J Chen
摘要
An important and often discussed research problem in statistics is how to compare several populations; examples arise in medical science, engineering, finance and other fields. Often population means or medians are compared. However, one population may have a higher mean income, for example, because of a small number of super-rich individuals; the mean therefore may not reflect the wealth of the general population. Instead, an index of the degree of stochastic dominance of one population over another would better reflect their relative wealth. Currently, we can estimate such an index under restrictive conditions, but there is no generic estimator with a known asymptotic distribution. In this paper, we suggest linking the populations via the density ratio model. Under this model, we develop an empirical likelihood estimator and establish its asymptotic normality. In addition, we improve the estimation efficiency by examining the similarities between the populations. Furthermore, we provide a valid bootstrap method for hypothesis testing and the construction of confidence intervals. Simulation experiments show that the proposed estimator substantially improves the estimation efficiency and power of the test, and leads to confidence intervals with satisfactorily precise coverage probabilities. It is also robust with respect to mild model misspecification. Two examples are given to demonstrate the usefulness of both the method and the concept. *(abstract via OpenAlex)*
SiM Testing & Uncertainty Clinical Trials · 发表于 2019-01-22
Michael A. Proschan, Lori E. Dodd
摘要
As randomization methods use more information in more complex ways to assign patients to treatments, analysis of the resulting data becomes challenging. The treatment assignment vector and outcome vector become correlated whenever randomization probabilities depend on data correlated with outcomes. One straightforward analysis method is a re‐randomization test that fixes outcome data and creates a reference distribution for the test statistic by repeatedly re‐randomizing according to the same randomization method used in the trial. This article reviews re‐randomization tests, especially in nonstandard settings like covariate‐adaptive and response‐adaptive randomization. We show that re‐randomization tests provide valid inference in a wide range of settings. Nonetheless, there are simple examples demonstrating limitations.
Biometrika Other · 发表于 2019-01-22
J E Johndrow, K Lum, D Manrique-Vallier
摘要
Population estimation methods are used for estimating the size of a population from samples of individuals. In many applications, the probability of being observed in the sample varies across individuals, resulting in sampling bias. We show that in this setting, estimators of the population size have high and sometimes infinite risk, leading to large uncertainty in the population size. As an alternative, we propose estimating the population of individuals with observation probability exceeding a small threshold. We show that estimators of this quantity have lower risk than estimators of the total population size. The proposed approach is shown empirically to result in large reductions in mean squared error in a common model for capture-recapture population estimation with heterogeneous capture probabilities. *(abstract via OpenAlex)*
SiM High-Dimensional Bayesian Methods · 发表于 2019-01-22
Sandrine Boulet, Moreno Ursino, Peter Thall, Anne‐Sophie Jannot, Sarah Zohar
摘要
Using clinical data to model the medical decisions behind sequential treatment actions raises methodological challenges. Physicians often have access to many covariates that may be used when making sequential treatment decisions for individual patients. Statistical variable selection methods may help finding which of these variables are used for this decision in everyday practice. When the sample size is not large, Bayesian variable selection methods can address this setting and allow for expert information to be incorporated into prior distributions. Motivated by clinical practice data involving repeated dose adaptation for Irinotecan in colorectal metastatic cancer, we propose a modification of the stochastic search variable selection (SSVS) method, which we call weight‐based SSVS (WBS). We use clinical relevance weights elicited from physician experts to construct prior distributions, with the goal to identify the most influential toxicities and other covariates used for dose adjustment. We evaluate and compare the WBS model performance to the Lasso and SSVS through an extensive simulation study. The simulations show that WBS has better performance and lower rates of false positives and false negatives than the other methods but depends strongly on the covariate weights.
Biometrics Genetics & Omics · 发表于 2019-01-22
Vasyl Zhabotynsky, Kaoru Inoue, Terry Magnuson, J. Mauro Calabrese, Wei Sun
摘要
RNA sequencing allows one to study allelic imbalance of gene expression, which may be due to genetic factors or genomic imprinting (i.e., higher expression of maternal or paternal allele). It is desirable to model both genetic and parent-of-origin effects simultaneously to avoid confounding and to improve the power to detect either effect. In studies of genetically tractable model organisms, separation of genetic and parent-of-origin effects can be achieved by studying reciprocal cross of two inbred strains. In contrast, this task is much more challenging in outbred populations such as humans. To address this challenge, we propose a new framework to combine experimental strategies and novel statistical methods. Specifically, we propose to study genetic and imprinting effects in family trios with RNA-seq data from the children and genotype data from both parents and children, and quantify genetic effects by cis-eQTLs. Towards this end, we have extended our method that studies the eQTLs of RNA-seq data (Sun, Biometrics 2012, 68(1): 1–11) to model both cis-eQTL and parent-of-origin effects, and evaluated its performance using extensive simulations. Since sample size may be limited in family trios, we have developed a data analysis pipeline that borrows information from external data of unrelated individuals for cis-eQTL mapping. We have also collected RNA-seq data from the children of 30 family trios, applied our method to analyze this dataset, and identified some previously reported imprinted genes as well as some new candidates of imprinted genes.
Biometrics Longitudinal Data Missing Data & Measurement Error · 发表于 2019-01-22
Li Su, Qiuju Li, Jessica K. Barrett, Michael J. Daniels
摘要
Shared parameter models (SPMs) are a useful approach to addressing bias from informative dropout in longitudinal studies. In SPMs it is typically assumed that the longitudinal outcome process and the dropout time are independent, given random effects and observed covariates. However, this conditional independence assumption is unverifiable. Currently, sensitivity analysis strategies for this unverifiable assumption of SPMs are underdeveloped. In principle, parameters that can and cannot be identified by the observed data should be clearly separated in sensitivity analyses, and sensitivity parameters should not influence the model fit to the observed data. For SPMs this is difficult because it is not clear how to separate the observed data likelihood from the distribution of the missing data given the observed data (i.e., ‘extrapolation distribution’). In this article, we propose a new approach for transparent sensitivity analyses for informative dropout that separates the observed data likelihood and the extrapolation distribution, using a typical SPM as a working model for the complete data generating mechanism. For this model, the default extrapolation distribution is a skew-normal distribution (i.e., it is available in a closed form). We propose anchoring the sensitivity analysis on the default extrapolation distribution under the specified SPM and calibrate the sensitivity parameters using the observed data for subjects who drop out. The proposed approach is used to address informative dropout in the HIV Epidemiology Research Study.
SiM Diagnostics & Prediction · 发表于 2019-01-21
Michael J. Pencina, Chirag R. Parikh, Paul L. Kimmel, Nancy R. Cook, Josef Coresh, Harold I. Feldman, Andrea Foulkes, Phyllis A. Gimotty, Chi‐yuan Hsu, Kevin Lemley, Peter Song, Kenneth Wilkins, Daniel R. Gossett, Yining Xie, Robert A. Star
摘要
The last two decades have witnessed an explosion in research focused on the development and assessment of novel biomarkers for improved prognosis of diseases. As a result, best practice standards guiding biomarker research have undergone extensive development. Currently, there is great interest in the promise of biomarkers to enhance research efforts and clinical practice in the setting of chronic kidney disease, acute kidney injury, and glomerular disease. However, some have questioned whether biomarkers currently add value to the clinical practice of nephrology. The current state of the art pertaining to statistical analyses regarding the use of such measures is critical. In December 2014, the National Institute of Diabetes and Digestive and Kidney Diseases convened a meeting, “Toward Building Better Biomarker Statistical Methodology,” with the goals of summarizing the current best practice recommendations and articulating new directions for methodological research. This report summarizes its conclusions and describes areas that need attention. Suggestions are made regarding metrics that should be commonly reported. We outline the methodological issues related to traditional metrics and considerations in prognostic modeling, including discrimination and case mix, calibration, validation, and cost‐benefit analysis. We highlight the approach to improved risk communication and the value of graphical displays. Finally, we address some “new frontiers” in prognostic biomarker research, including the competing risk framework, the use of longitudinal biomarkers, and analyses in distributed research networks.
SiM Clinical Trials · 发表于 2019-01-21
Kelsey L. Grantham, Jessica Kasza, Stephane Heritier, Karla Hemming, Andrew B. Forbes
摘要
A requirement for calculating sample sizes for cluster randomized trials (CRTs) conducted over multiple periods of time is the specification of a form for the correlation between outcomes of subjects within the same cluster, encoded via the within‐cluster correlation structure. Previously proposed within‐cluster correlation structures have made strong assumptions; for example, the usual assumption is that correlations between the outcomes of all pairs of subjects are identical (“uniform correlation”). More recently, structures that allow for a decay in correlation between pairs of outcomes measured in different periods have been suggested. However, these structures are overly simple in settings with continuous recruitment and measurement. We propose a more realistic “continuous‐time correlation decay” structure whereby correlations between subjects' outcomes decay as the time between these subjects' measurement times increases. We investigate the use of this structure on trial planning in the context of a primary care diabetes trial, where there is evidence of decaying correlation between pairs of patients' outcomes over time. In particular, for a range of different trial designs, we derive the variance of the treatment effect estimator under continuous‐time correlation decay and compare this to the variance obtained under uniform correlation. For stepped wedge and cluster randomized crossover designs, incorrectly assuming uniform correlation will underestimate the required sample size under most trial configurations likely to occur in practice. Planning of CRTs requires consideration of the most appropriate within‐cluster correlation structure to obtain a suitable sample size.
SiM Spatial & Time Series · 发表于 2019-01-21
Ai Kawamori, Keiichi Fukaya, Masumi Kitazawa, Makio Ishiguro
摘要
The menstrual cycle is divided into hypothermic and hyperthermic phases based on the periodic shift in the basal body temperature (BBT), reflecting events occurring in the ovary. In the present study, we proposed a state‐space model that explicitly incorporates the biphasic nature of the menstrual cycle, in which the probability density distributions for the advancement of the menstrual phase and that for the BBT switch depending on a latent state variable. Our model derives the predictive distribution of the day of the next menstruation onset that is adaptively adjusted by accommodating new observations of the BBT sequentially. It also enables us to obtain conditional probabilities of the woman being in the early or late stages of the cycle, which can be used to identify the duration of hypothermic and hyperthermic phases, possibly as well as the day of ovulation. By applying the model to real BBT and menstruation data, we show that the proposed model can properly capture the biphasic characteristics of menstrual cycles, providing a good prediction of the menstruation onset in a wide range of age groups. The application of the proposed model to a large data set containing 25 622 cycles provided by 3533 women further highlighted the between‐age differences in the population characteristics of menstrual cycles, suggesting its wide applicability.
SiM Nonparametric & Semiparametric Causal Inference · 发表于 2019-01-20
Li Zou, Albert Vexler, Jihnhee Yu, Hongzhi Wan
摘要
In health‐related experiments, treatment effects can be identified using paired data that consist of pre‐ and posttreatment measurements. In this framework, sequential testing strategies are widely accepted statistical tools in practice. Since performances of parametric sequential testing procedures vitally depend on the validity of the parametric assumptions regarding underlying data distributions, we focus on distribution‐free mechanisms for sequentially evaluating treatment effects. In fixed sample size designs, the density‐based empirical likelihood (DBEL) methods provide powerful nonparametric approximations to optimal Neyman‐Pearson–type statistics. In this article, we extend the DBEL methodology to develop a novel sequential DBEL testing procedure for detecting treatment effects based on paired data. The asymptotic consistency of the proposed test is shown. An extensive Monte Carlo study confirms that the proposed test outperforms the conventional sequential Wilcoxon signed‐rank test across a variety of alternatives. The excellent applicability of the proposed method is exemplified using the ventilator‐associated pneumonia study that evaluates the effect of Chlorhexidine Gluconate treatment in reducing oral colonization by pathogens in ventilated patients.
JASA Bayesian Methods · 发表于 2019-01-17
Yingbo Li, Merlise A. Clyde
摘要
Mixtures of Zellner’s g-priors have been studied extensively in linear models and have been shown to have numerous desirable properties for Bayesian variable selection and model averaging. Several extensions of g-priors to generalized linear models (GLMs) have been proposed in the literature; however, the choice of prior distribution of g and resulting properties for inference have received considerably less attention. In this article, we unify mixtures of g-priors in GLMs by assigning the truncated Compound Confluent Hypergeometric (tCCH) distribution to 1/(1 + g), which encompasses as special cases several mixtures of g-priors in the literature, such as the hyper-g, Beta-prime, truncated Gamma, incomplete inverse-Gamma, benchmark, robust, hyper-g/n, and intrinsic priors. Through an integrated Laplace approximation, the posterior distribution of 1/(1 + g) is in turn a tCCH distribution, and approximate marginal likelihoods are thus available analytically, leading to “Compound Hypergeometric Information Criteria” for model selection. We discuss the local geometric properties of the g-prior in GLMs and show how the desiderata for model selection proposed by Bayarri et al., such as asymptotic model selection consistency, intrinsic consistency, and measurement invariance may be used to justify the prior and specific choices of the hyper parameters. We illustrate inference using these priors and contrast them to other approaches via simulation and real data examples. The methodology is implemented in the R package BAS and freely available on CRAN. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Networks & Graphs · 发表于 2019-01-16
Tim P. Morris, Ian R. White, Michael J. Crowther
摘要
Simulation studies are computer experiments that involve creating data by pseudo‐random sampling. A key strength of simulation studies is the ability to understand the behavior of statistical methods because some “truth” (usually some parameter/s of interest) is known from the process of generating the data. This allows us to consider properties of methods, such as bias. While widely used, simulation studies are often poorly designed, analyzed, and reported. This tutorial outlines the rationale for using simulation studies and offers guidance for design, execution, analysis, reporting, and presentation. In particular, this tutorial provides a structured approach for planning and reporting simulation studies, which involves defining aims, data‐generating mechanisms, estimands, methods, and performance measures (“ADEMP”); coherent terminology for simulation studies; guidance on coding simulation studies; a critical discussion of key performance measures and their estimation; guidance on structuring tabular and graphical presentation of results; and new graphical presentations. With a view to describing recent practice, we review 100 articles taken from Volume 34 of Statistics in Medicine , which included at least one simulation study and identify areas for improvement.
SiM Causal Inference · 发表于 2019-01-16
Tri‐Long Nguyen, Thomas P.A. Debray
摘要
In nonrandomised studies, inferring causal effects requires appropriate methods for addressing confounding bias. Although it is common to adopt propensity score analysis to this purpose, prognostic score analysis has recently been proposed as an alternative strategy. While both approaches were originally introduced to estimate causal effects for binary interventions, the theory of propensity score has since been extended to the case of general treatment regimes. Indeed, many treatments are not assigned in a binary fashion and require a certain extent of dosing. Hence, researchers may often be interested in estimating treatment effects across multiple exposures. To the best of our knowledge, the prognostic score analysis has not been yet generalised to this case. In this article, we describe the theory of prognostic scores for causal inference with general treatment regimes. Our methods can be applied to compare multiple treatments using nonrandomised data, a topic of great relevance in contemporary evaluations of clinical interventions. We propose estimators for the average treatment effects in different populations of interest, the validity of which is assessed through a series of simulations. Finally, we present an illustrative case in which we estimate the effect of the delay to Aspirin administration on a composite outcome of death or dependence at 6 months in stroke patients.
Biometrics High-Dimensional Testing & Uncertainty · 发表于 2019-01-16
Yang Li, Yuetian Luo, Davide Ferrari, Xiaonan Hu, Yichen Qin
摘要
In this article, we introduce the concept of model confidence bounds (MCB) for variable selection in the context of nested models. Similarly to the endpoints in the familiar confidence interval for parameter estimation, the MCB identifies two nested models (upper and lower confidence bound models) containing the true model at a given level of confidence. Instead of trusting a single selected model obtained from a given model selection method, the MCB proposes a group of nested models as candidates and the MCB's width and composition enable the practitioner to assess the overall model selection uncertainty. A new graphical tool—the model uncertainty curve (MUC)—is introduced to visualize the variability of model selection and to compare different model selection procedures. The MCB methodology is implemented by a fast bootstrap algorithm that is shown to yield the correct asymptotic coverage under rather general conditions. Our Monte Carlo simulations and real data examples confirm the validity and illustrate the advantages of the proposed method.
Biometrika Other · 发表于 2019-01-16
Xu He
摘要
We propose a new method to construct maximin distance designs with arbitrary numbers of dimensions and points. The proposed designs hold interleaved-layer structures and are by far the best maximin distance designs in four or more dimensions. Applicable to distance measures with equal or unequal weights, our method is useful for emulating computer experiments when a relatively accurate a priori guess on variable importance is available. *(abstract via OpenAlex)*
Biometrics Survival Analysis Nonparametric & Semiparametric · 发表于 2019-01-16
Marlena Maziarz, Yukun Liu, Jing Qin, Ruth M. Pfeiffer
摘要
We propose and study a fully efficient method to estimate associations of an exposure with disease incidence when both, incident cases and prevalent cases, i.e., individuals who were diagnosed with the disease at some prior time point and are alive at the time of sampling, are included in a case-control study. We extend the exponential tilting model for the relationship between exposure and case status to accommodate two case groups, and correct for the survival bias in the prevalent cases through a tilting term that depends on the parametric distribution of the backward time, i.e., the time from disease diagnosis to study enrollment. We construct an empirical likelihood that also incorporates the observed backward times for prevalent cases, obtain efficient estimates of odds ratio parameters that relate exposure to disease incidence and propose a likelihood ratio test for model parameters that has a standard chi-squared distribution. We quantify the changes in efficiency of association parameters when incident cases are supplemented with, or replaced by, prevalent cases in simulations. We illustrate our methods by estimating associations of single nucleotide polymorphisms (SNPs) with breast cancer incidence in a sample of controls, incident and prevalent cases from the U.S. Radiologic Technologists Health Study.
Biometrics Bayesian Methods · 发表于 2019-01-16
Andrea Tancredi
SMMR Clinical Trials Bayesian Methods · 发表于 2019-01-16
Haiyan Zheng, Lisa V Hampson, Simon Wandel
摘要
Before a first-in-man trial is conducted, preclinical studies are performed in animals to help characterise the safety profile of the new medicine. We propose a robust Bayesian hierarchical model to synthesise animal and human toxicity data, using scaling factors to translate doses administered to different animal species onto an equivalent human scale. After scaling doses, the parameters of dose-toxicity models intrinsic to different animal species can be interpreted on a common scale. A prior distribution is specified for each translation factor to capture uncertainty about differences between toxicity of the drug in animals and humans. Information from animals can then be leveraged to learn about the relationship between dose and risk of toxicity in a new phase I trial in humans. The model allows human dose-toxicity parameters to be exchangeable with the study-specific parameters of animal species studied so far or non-exchangeable with any of them. This leads to robust inferences, enabling the model to give greatest weight to the animal data with parameters most consistent with human parameters or discount all animal data in the case of non-exchangeability. The proposed model is illustrated using a case study and simulations. Numerical results suggest that our proposal improves the precision of estimates of the toxicity rates when animal and human data are consistent, while it discounts animal data in cases of inconsistency.
SiM Spatial & Time Series · 发表于 2019-01-15
Ezra Gayawan, Samson B. Adebayo, Elisabeth Waldmann
摘要
The average nutritional status of children in Nigeria is, just as in most developing countries, still in an alarmingly bad condition. Prior studies have shown that this status relies on a series of different influences and can be measured by three anthropometric variables for stunting, wasting, and underweight. Different regression modeling techniques have been adopted over the years to explain the determinants and spatial clustering. Those indicators, however, show patterns that are not necessarily full filling requirements for ordinary regression models for the mean and are correlated among each other, a fact that has until now been ignored by most studies. Methods to model outcomes in the light of both, the whole distribution of and the correlation between two or more outcomes based on a set of covariates, have lately been developed. The aim of this paper is to make use of those methods to explain the underlying spatial structure in malnutrition in Nigeria. The study brings to limelight the pattern of spread as well as the interwoven relationships among childhood malnutrition indicators that would have otherwise remained unknown in Nigeria.